isoproterenol has been researched along with daunorubicin in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Baserga, R; Sasaki, T | 1 |
| Bachur, NR; Bernstein, JG; Thompson, WL | 1 |
| Casassus, P; Chaux, F; Cupa, M; Larmignat, P; Leroux, G; Pourriat, JL | 1 |
| Jacobs, P; Opie, LH; Saman, S | 1 |
| Borgers, M | 1 |
| Lushnikova, EL; Nepomnyashchikh, LM; Semenov, DE | 1 |
| Fang, QJ; He, RL; Lian, JB; Wu, ZJ; Yu, J | 1 |
1 review(s) available for isoproterenol and daunorubicin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
9 other study(ies) available for isoproterenol and daunorubicin
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Cytoplasmic ribonucleic acid synthesis in the prereplicative phase of isoproterenol-induced cell proliferation.
Topics: Animals; Cell Division; Cycloheximide; Cytoplasm; Daunorubicin; DNA; Electrophoresis, Disc; Isoproterenol; Male; Mice; Ribosomes; RNA; Salivary Glands; Tritium; Uridine | 1970 |
Effect of daunomycin on cardiovascular responses to isoproterenol and norepinephrine.
Topics: Animals; Blood Pressure; Daunorubicin; Depression, Chemical; Dogs; Heart; Heart Rate; Isoproterenol; Muscle Contraction; Norepinephrine; Stimulation, Chemical | 1968 |
[Immediate cardiac toxicity of rubidazone. A case reversible by isoproterenol].
Topics: Antibiotics, Antineoplastic; Daunorubicin; Drug Hypersensitivity; Female; Hemodynamics; Humans; Isoproterenol; Leukemia, Myeloid, Acute; Middle Aged; Shock, Cardiogenic | 1983 |
Mechanism of acute anthracycline cardiotoxicity in isolated rat hearts: carminomycin versus daunomycin.
Topics: Animals; Atrial Function; Calcium; Carubicin; Coenzymes; Daunorubicin; Digoxin; Heart; Heart Atria; In Vitro Techniques; Isoproterenol; Male; Rats; Ubiquinone | 1984 |
The role of calcium in the toxicity of the myocardium.
Topics: Acute Disease; Animals; Calcium; Cardiomyopathies; Chronic Disease; Coronary Disease; Daunorubicin; Dogs; Doxorubicin; Heart; Humans; Isoproterenol; Microscopy, Electron; Mitochondria, Heart; Myocardium | 1981 |
Alterative and plastic insufficiency of cardiomyocytes: isoproterenol-induced damage to myocardium during anthracycline cardiomyopathy.
Topics: Animals; Antibiotics, Antineoplastic; Cardiomyopathies; Cardiotonic Agents; Cell Death; Daunorubicin; Isoproterenol; Myocardial Contraction; Myocardium; Rats; Rats, Wistar | 2001 |
[Sodium ferulate protects against daunorubicin-induced cardiotoxicity in juvenile rats].
Topics: Animals; Blood Pressure; Cardiotoxicity; Coumaric Acids; Daunorubicin; Heart; Heart Rate; Isoproterenol; Male; Myocardium; Protective Agents; Rats; Rats, Sprague-Dawley; Troponin I | 2015 |